bromodeoxyuridine

DRUG2 trials

Sponsors

Rush University Medical Center, National Cancer Institute (NCI)

Conditions

LeukemiaStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer

Phase 2

Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

CompletedNCT00003832

National Cancer Institute (NCI)Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage I Prostate Cancer

Start: 1999-07-31Updated: 2013-01-25

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

WithdrawnNCT00003405

Rush University Medical CenterLeukemia

Start: 1998-04-30End: 1999-04-30Updated: 2021-10-14